Letter to the editor

Von Andrian UH , Engelhardt B. a4 integrins as therapeutic targets in autoimmune disease . N Engl J Med 2003; 348: 68-72 .

Burkely LC , Jakubowski A , Newman BM , Rosa MD , Chi-Rosso G , Lobb RR. Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-depedent T cell proliferation . Eur J Immunol 1991; 21: 2871-2875 .

Madri JA , Graesser D , Haas T. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration . Biochem Cell Biol 1996; 74: 749-757 .

Tubridy N , Behan PO , Capildeo R , Chaudhuri A , Forbes R , Hawkins CP. The effect of anti-a4 integrin antibody on brain lesion activity in MS . Neurology 1999; 53: 466-472 .

Miller DH , Khan OA , Sheremata WA , Blumhardt LD , Rice GP , Libonati, MA et al. A controlled trial of Natalizumab for relapsing multiple sclerosis . N Engl J Med 2003; 348: 15-23 .

Sehgal VN , Bl Khchandani R , Koranne RV , Nayar M , Saxena HMK. Histopathologic evaluation of griseofulvin therapy in lichen planus. A double-blind controlled study . Dermatologica 1980; 161: 22-27 .

Tamaki K , Osada A , Tsukamoto K , Ohtake N , Furue M. Treatment of plasma cell cheilitis with griseofulvin . JAm Acad Dermatol 1994; 30: 789-790 .

Ferri C , Bernini L , Bombardieri S , Pasero G. Long-term griseofulvin treatment for progressive systemic sclerosis . Scand J Rheumatol 1986; 15: 356-362 .

Tamaki K , Yasaka N , Osada A , Shibaaki N , Furne M. Successful treatment of pigmented purpuric dermatosis with griseofulvin . Br J Dermatol 1995; 132: 159-160 .

Rowel NR , Goodfield MJD. The connective tissue diseases. In Champion RH , Burton JL , Ebling FJG eds. Rook/Ebling/Wilkinson textbook of dermatology, sixth edition, Volume 2. Oxford: Blackwell Scientific Publications : 1999; 2509-2509.

Asahina A , Tada Y , Nakamura K , Tamaki K. Griseofulvin has a potential to modulate the expression of cell adhesion molecules on leukocytes and vascular endothelial cells . Int Immunopharmacol 2001; 1: 75-83 .